Septorhinoplasty Post-operative Pain Control With SPG Nerve Block

Deviated Nasal Septum Clinical Trial

Official title:
Post-operative Pain Control With Sphenopalantine Ganglion Nerve Block in Septorhinoplasty Patients

Status Recruiting

Clinical Trial Summary

Maxillary nerve blocks have been shown to significantly reduce post-operative pain and analgesic intake during the 24-hour period following sinus surgery. This randomized, double-blinded, placebo-controlled study will investigate blocks of the pterygopalatine fossa using a suprazygomatic approach during septorhinoplasty surgery. It is the investigator's hypothesis that this technique will result in decreased post-operative pain and opioid use, and the morbidity associated with it.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05667324
Study type	Interventional
Source	University of Florida
Contact	Jeffrey D Johnson, MD
Phone	352-273-5199
Email	jeffrey.johnson@ent.ufl.edu
Status	Recruiting
Phase	Phase 4
Start date	April 12, 2023
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01370915` - Perioperative Administration of Pregabalin for Pain After Septoplasty	N/A
Completed	`NCT02231216` - Quality of Life Study About the Role of Turbinectomy in Rhinoseptoplasty	N/A
Enrolling by invitation	`NCT03780478` - Preoperative Nerve Block for Rhinoplasty/Septoplasty	Phase 1/Phase 2
Completed	`NCT03427502` - Anterior Ethmoidal Nerve Block in Prevention of Postoperative Agitation	N/A
Completed	`NCT00957502` - ENTact™ Septal Stapler Shelf Life Extension	N/A
Recruiting	`NCT01278719` - The Factors Associated With the Formation of Nasal polyp-a Case Control and Descriptive Study	N/A
Completed	`NCT02905344` - Effectiveness of Using 3D Printed Models to Educate Otolaryngology (Ear, Nose, Nose and Throat (ENT)) Patients About Surgery: A Survey	N/A